Pharming looks beyond regulatory hurdle
Interviewee/Contributor
Rein Strijker
Organisation
Pharming Group NV
Research Directory
How Addex Pharmaceuticals secured two multimilion dollar deals with Merck
Interviewee/ContributorVincent MutelOrganisationAddex PharmaceuticalsTête à tête with the EMEA can progress advanced therapies
Interviewee/ContributorMarisa Papaluca-AmatiOrganisationEuropean Medicines Agency4SC does its high throughput screening on a computer
Interviewee/ContributorUlrich DauerOrganisation4SC AGHow MorphoSys leverages its antibody library
Interviewee/ContributorSimon MoroneyOrganisationMorphoSys AGFour smart chemists meet two billionaire investors
Interviewee/ContributorUlrich DauerOrganisation4SC AGHow MorphoSys leverages its antibody library
Interviewee/ContributorSimon MoroneyOrganisationMorphoSys AGReNeuron stakes out a position in the race for stem cell therapies
Interviewee/ContributorMichael HuntOrganisationReNeuron Group PlcUK to use stem cells to test drugs for safety
Interviewee/ContributorPhilip WrightOrganisationStem Cells for Safer Medicines LtdMMI turns from giving advice to developing challenging products
Interviewee/ContributorDavid BestOrganisationMedical Marketing International Group plc